openPR Logo
Press release

Mystic Pharmaceuticals to Present at 4th Ocular Diseases & Drug Discovery Conference

01-12-2012 08:04 AM CET | Health & Medicine

Press release from: Mystic Pharmaceuticals, Inc.

AUSTIN, TX – 12 January 2012 – Mystic Pharmaceuticals, Inc. announced today that President and CEO Timothy Sullivan will present at the 4th Ocular Diseases and Drug Delivery Conference in Las Vegas, Nevada on February 27 – 28, 2012. This annual conference brings together thought leaders and innovators in ocular diseases, drug development and drug delivery to collaborate on the latest research and discovery for combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, uveitis and other eye diseases. Leading researchers from academia and the pharma industry including Allergan, Genzyme, Pfizer and others will present the latest advances in ophthalmic drug discovery, development and delivery.

Timothy Sullivan will present on the topic of “Novel Advances in Ophthalmic Drug Delivery, Adherence Packaging and Improving the Patient Experience” on February 27th. Mr. Sullivan’s presentation will provide a technical overview of Mystic’s VersiDoser® Delivery Platform including patient acceptance data from a recent clinical trial for macular degeneration. The VersiDoser® Delivery Platform provides patients the capability to reliably and easily self-administer ophthalmic treatments. “More than 75% of the patients participating in this clinical trial preferred the VersiDoser® Delivery System over traditional eye drop delivery. These results correlate to earlier focus group studies we have conducted,” stated Mr. Sullivan. “In additional to enhancing the patient experience the VersiDoser® Platform provides pharma manufacturers with the option for preservative free formulations, calibrated precision dose delivery and a means of establishing competitive market differentiation for a wide range of existing drugs coming off patent or new pipeline biopharmaceuticals” added Sullivan.

Mystic Pharmaceuticals™ is an integrated specialty pharmaceutical company based in Austin, Texas. Mystic provides precision unit dose delivery solutions for pharmaceuticals, biopharmaceuticals and vaccines for intranasal, ophthalmic, sublingual, and otic applications. Mystic combines its novel delivery systems with pharmaceuticals and biologics under development by Mystic and its partners, to meet the expanding global market demand for healthcare products that are safer, simpler to use and cost effective. For more information please visit the Mystic website at: www.mysticpharmaceuticals.com

Mystic Pharmaceuticals, Inc.
2006 Windy Terrace
Cedar Park, TX 78613
Media Contact
Melissa Brandt
+(1) 512-918-2900 ext. 224
mbrandt@mysticpharmaceuticals.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mystic Pharmaceuticals to Present at 4th Ocular Diseases & Drug Discovery Conference here

News-ID: 206807 • Views:

More Releases for Sullivan

Oliver Sullivan presents: Tech House Hit SAFARI
Oliver Sullivan, the busy Swiss DJ and producer, releases his new tech house single "Safari". Known for his vibrant and energetic style, Sullivan continues to gain momentum in the EDM scene with this release. Building on the success of his previous tracks such as "Summer On Me" and "Never Let You Go", which reached millions of streams, "Safari" further cements his reputation as a purveyor of fresh and dynamic dance music. His
Kruger Carson promotes attorney Ryan Sullivan to partner
(AUSTIN-SAN ANTONIO) - Kruger Carson, PLLC, has promoted attorney Ryan Sullivan to partner of the firm, where he handles a wide range of real estate matters for Kruger Carson's clients in Texas and around the country. Sullivan focuses primarily on commercial real estate transactions, including acquisitions and dispositions, lending, leasing, development, and partnerships. "Ryan joined our firm three years ago and has been doing extraordinary work since day one," said Brad
Sullivan State Farm toy drive helps Cape Coral children
Sullivan State Farm will be bringing many smiles to hundreds of children and families in the Cape Coral community this holiday season. State Farm agents Dawn and Michael Sullivan at 2708 Santa Barbara Blvd., #120, Cape Coral are collecting new, unwrapped toys and gifts through Dec. 16 to benefit Alexander’s Toy Drive in conjunction with the Cape Coral Police Department. The Sullivan Agency will serve as a drop off point for those
Real Estate Attorney James Sullivan Joins Gardere in Dallas
DALLAS - Gardere Wynne Sewell LLP is pleased to announce that Dallas attorney James J. Sullivan has joined the Firm as a partner in the Real Estate Practice Group. Mr. Sullivan’s practice focuses on the representation of developers, property owners, commercial landlords and tenants, and borrowers and lenders in real estate and mortgage transactions. He will concentrate on the preparation and negotiation of complex commercial leases for offices and retail establishments. “We
Preton Recognized with Product Innovation Award from Frost & Sullivan
Company’s PretonSaver™ Enterprise software recognized for intelligently reducing the costs and environmental impact of organizational printing Tel Aviv, Israel (April 5, 2011) – Preton Ltd., the leading provider of toner and ink saving software solutions, today announced that the company has been recognized with the 2011 Global New Product Innovation Award in Print Management Solutions by the leading analyst firm Frost & Sullivan for its PretonSaver™ Enterprise software. This award from
Frost & Sullivan awards first prize to Sputnik Engineering
Global research platform distinguishes the Swiss inverter manufacturer with the "Price Performance Value Leadership of the Year Award 2010" Biel, 16 November 2010. Today, Sputnik Engineering has received the prestigious Frost & Sullivan Award. The analysts with the global research platform examined the price/performance ratio, the features, the user friendliness, service and customer orientation of the Swiss manufacturer and compared them with the achievements of its most important competitors in the